Discussion of "Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development"

Research output: Contribution to journal › Article › peer-review

2 Citations (SciVal)

Original language	English
Pages (from-to)	293-298
Number of pages	6
Journal	Journal of Biopharmaceutical Statistics
Volume	16 May-Jun
Issue number	3
DOIs	https://doi.org/10.1080/10543400600609700
Publication status	Published - 2006

ID number: ISI:000237604900005

Access to Document

@article{66b662fe602f447a847b4dedc090290b,

title = "Discussion of {"}Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development{"}",

author = "C Jennison and Turnbull, \{B W\}",

note = "ID number: ISI:000237604900005",

year = "2006",

doi = "10.1080/10543400600609700",

language = "English",

volume = "16 May-Jun",

pages = "293--298",

journal = "Journal of Biopharmaceutical Statistics",

issn = "1054-3406",

publisher = "Taylor and Francis",

number = "3",

}

TY - JOUR

T1 - Discussion of "Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development"

AU - Jennison, C

AU - Turnbull, B W

N1 - ID number: ISI:000237604900005

PY - 2006

Y1 - 2006

U2 - 10.1080/10543400600609700

DO - 10.1080/10543400600609700

M3 - Article

SN - 1054-3406

VL - 16 May-Jun

SP - 293

EP - 298

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

IS - 3

ER -